← Open Payments lookup

MATTHEW GALVIN: Open Payments

NPI 1598856221 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$834 in 43 payments from 11 companies in 2025. Trend: 2023 $2,570 · 2024 $2,015 · 2025 $834

Food & beverage: $834
CompanyPaymentsAmount
GENZYME CORPORATION8$245
ABBVIE INC.10$142
Lilly USA, LLC9$122
E.R. Squibb & Sons, L.L.C.3$66
Incyte Corporation3$63
Galderma Laboratories, L.P.3$51
Novartis Pharmaceuticals Corporation2$48
Organon LLC2$31
UCB, Inc.1$31
Amgen Inc.1$23

Products named: DUPIXENT, TALTZ, Sotyktu, OPZELURA, NEMLUVIO, SKYRIZI, Bimzelx, RINVOQ.

Industry payments across MA — which companies pay providers there.